Apteki 36.6 (APTK) EV/EBITDA MSFO (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 21.6 | 8.28 | 5.30 | 4.07 | ||||
| Changes by years, y/y, % | -100% | -62% | -36% | -19.1% | |||||
Apteki 36.6. EV/EBITDA
Apteki 36.6. EV/EBITDA, changes, %
Apteki 36.6 (APTK) EV/EBITDA MSFO (quarter values) |
||||||||
| 2023Q4 | 2024Q2 | 2024Q4 | 2025Q2 | 2025Q4 | LTM ? | |||
| EV/EBITDA | ? | 17.5 | 12.7 | 9.57 | 5.30 | 4.07 | ||
| Changes by years, y/y, % | -45% | -58% | ||||||
| Changes by quarters, q/q, % | -27% | -25% | -45% | |||||